Metoclopramide | Rikkunshito | P | |
---|---|---|---|
n = 13 | n = 10 | ||
Age (years) | 75 ± 11 | 70 ± 13 | 0.289 |
Sex (male/female) | 8/5 | 5/5 | 0.685 |
Height (cm) | 163 ± 9 | 162 ± 9 | 0.841 |
Weight (kg) | 58.8 ± 10.8 | 60.4 ± 12.1 | 0.770 |
Body surface area (m2) | 1.63 ± 0.16 | 1.64 ± 0.20 | 0.914 |
APACHE II score | 28 ± 6 | 29 ± 10 | 0.774 |
Reason for admission to the ICU | |||
Post-cardiac arrest | 5 | 4 | |
Trauma | 3 | 2 | |
Cerebral infarction/hemorrhage | 0 | 3 | 0.336 |
Burn | 2 | 0 | |
Others | 3 | 1 | |
Days of enrollment after admission to the ICU | 3.5 ± 1.5 | 3.0 ± 2.3 | 0.563 |
C-reactive protein | 8.3 ± 7.5 | 5.6 ± 6.7 | 0.385 |
Basal energy expenditure (kcal/day) | 1,219 ± 161 | 1,255 ± 239 | 0.703 |
Target volume of enteral feeding (mL/h) | 46.7 ± 7.8 | 51.0 ± 12.9 | 0.341 |
Observational period (day) | 9.3 ± 2.2 | 9.8 ± 0.6 | 0.430 |